ResMed (RMD) News

ResMed Adjusts CDI and Share Counts Amid Cross-Market Transfers and Buybacks

TipRanksSep 7 08:47

ResMed Chairman Emeritus Peter Farrell Sells Shares Under 10b5-1 Plan

TipRanksSep 7 06:32

Notable Healthcare Headlines for the Week: UnitedHealth, Moderna, and Medtronic in Focus

Seeking AlphaSep 6 21:05

Morgan Stanley Adjusts Price Target on ResMed to $225 From $227, Keeps Equalweight Rating

ResMed (RMD) has an average rating of overweight and mean price target of $261.07, according to analysts polled by FactSet.

MT NewswiresSep 3 18:06

ResMed Launches $450 Million Accelerated Share Buyback With Citibank

ResMed (RMD) said Tuesday it entered into a $450 million accelerated share repurchase agreement with Citigroup's (C) Citibank, funded with proceeds from the sale of its MatrixCare business and cash

MT NewswiresSep 2 05:54

ResMed Launches $450 Million Accelerated Share Repurchase

TipRanksSep 2 05:24

Express News | Resmed - Final Settlement of Asr Agreement Scheduled for December 2026 - SEC Filing

BreakingsSep 2 04:32

ResMed Is Maintained at Overweight by Keybanc

ResMed Is Maintained at Overweight by

Dow JonesAug 31 20:35

KeyBanc Maintains ResMed(RMD.US) With Buy Rating, Raises Target Price to $267

KeyBanc analyst Brett Fishbin maintains $ResMed(RMD.US)$ with a buy rating, and adjusts the target price from $255 to $267.According to TipRanks data, the analyst has a success rate of 50.0% and a

Futu NewsAug 31 16:32

Analysts Are Bullish on Top Healthcare Stocks: Resmed (RMD), Cytokinetics (CYTK)

TipRanksAug 31 16:01

Notable Healthcare Headlines for the Week: Veeva Systems, Boston Scientific in Focus

Seeking AlphaAug 30 21:05

MHealth Solutions Market Worth $275.44 Billion by 2031 - Exclusive Report by MarketsandMarkets

DELRAY BEACH, Fla., Aug. 28, 2026 /PRNewswire/ -- According to MarketsandMarkets, the mHealth Solutions Market is projected to reach USD 275.44 billion by 2031 from USD 109.05 billion in 2026, at a

PR NewswireAug 28 22:15

Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference

SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend

GlobeNewswireAug 28 04:05

RBC Capital Keeps Their Buy Rating on Integral Diagnostics Ltd. (IDX)

TipRanksAug 27 09:46

ResMed Tests Wearable PAP Device, Signaling Next Wave of Sleep Apnea Innovation

TipRanksAug 26 00:30

23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up With Resmed to Help Others Recognize the Signs

Reddick, a 13-time NASCAR Cup Series winner and 2026 Daytona 500 Champion, shares how prioritizing sleep health is an important part of his recovery and performance routineSAN DIEGO, Aug. 25, 2026 (

GlobeNewswireAug 25 21:00

Express News | 23Xi Racing Nascar Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams up With Resmed to Help Others Recognize the Signs

BreakingsAug 25 21:00

ResMed Updates FX Rate and Tax Details for ASX CDI Dividend

TipRanksAug 24 06:38

ResMed's New OSA Diagnostic Study Signals Next Wave in Home Sleep Testing

TipRanksAug 20 00:31

ResMed Initiated at Neutral by Rothschild & Co

ResMed Initiated at Neutral by Rothschild &

Dow JonesAug 19 22:57